Renaissance Capital logo

CPIX News

Cumberland Pharmaceuticals prices IPO at $17, below the range

Cumberland Pharmaceuticals, which sells specialty pharmaceuticals, including a new injectable treatment for pain and fever, raised $85 million by offering 5,000,000 shares at $17.00, below the expected range of $19.00 to $21.00. The Nashville, TN-based company...read more

Upcoming IPOs: Cumberland Pharmaceuticals, Emdeon, Starwood Property Trust

The following IPOs are expected to price this week:

...read more

Cumberland Pharmaceuticals increases proposed IPO deal size

Cumberland Pharmaceuticals, which sells specialty pharmaceuticals to the hospital and gastroenterology markets, raised the proposed deal size for its upcoming IPO on Friday. The Nashville,TN-based company now plans to raise $100 million by offering 5 million...read more

Cumberland Pharmaceuticals announces terms

Cumberland Pharmaceuticals, which focuses on the acquisition of branded prescription products in hospital acute care and gastroenterology, filed terms Monday for its upcoming IPO. The company plans to offer 6.3 million shares at a price range of $14 to $16. ...read more

Archived Headlines